958 related articles for article (PubMed ID: 20470309)
21. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
[TBL] [Abstract][Full Text] [Related]
22. Comparable transplant outcomes between local and shipped deceased-donor kidneys in Australia: analysis of Australia and New Zealand Dialysis and Transplant Registry 1992-2007.
Lim WH; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Feb; 15(1):124-32. PubMed ID: 20377780
[TBL] [Abstract][Full Text] [Related]
23. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.
Sola E; Gonzalez-Molina M; Cabello M; Burgos D; Ramos J; Gutierrez C; Lopez V; Soler J; de la Vega E; Hernandez D
Transplantation; 2010 Mar; 89(6):714-20. PubMed ID: 20035250
[TBL] [Abstract][Full Text] [Related]
24. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
25. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
26. Conversion to everolimus in kidney transplant recipients: to believe or not believe?
Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A
Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007
[TBL] [Abstract][Full Text] [Related]
27. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
28. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
30. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
31. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
32. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients.
Zaltzman JS; Boucher A; Busque S; Halloran PF; Landsberg DN; McAlister VC; Russell D; Shoker A; Shapiro J; Tchervenkov JI; Ferguson R
Clin Transplant; 2005 Feb; 19(1):26-32. PubMed ID: 15659130
[TBL] [Abstract][Full Text] [Related]
33. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
34. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
[TBL] [Abstract][Full Text] [Related]
35. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
[TBL] [Abstract][Full Text] [Related]
36. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
37. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
38. Acute rejection and late renal transplant failure: risk factors and prognosis.
Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
[TBL] [Abstract][Full Text] [Related]
39. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
40. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]